Tower Research Capital LLC (Trc) Bicycle Therapeutics PLC Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,665 shares of BCYC stock, worth $10,789. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,665
Previous 4,159
59.97%
Holding current value
$10,789
Previous $28,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BCYC
# of Institutions
107Shares Held
38MCall Options Held
37.7KPut Options Held
3.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$70.5 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$22.4 Million5.34% of portfolio
-
Armistice Capital, LLC New York, NY2.98MShares$19.3 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.95MShares$19.1 Million0.1% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$13 Million0.61% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $192M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...